Centessa Pharmaceuticals ($CNTA) generated 7 mentions from 2 distinct FinTwit voices over a 12-month period, with the first mention appearing on July 22, 2025, and the most recent on April 27, 2026. @adamfeuerstein contributed 4 mentions while @ssi_invest contributed 3 mentions, making biotech the dominant voice category discussing this ticker. The acquisition by Eli Lilly was announced on April 1, 2026, with a deal structure of $38.00 per share in cash plus up to $9.00 in contingent value rights tied to FDA milestones for ORX750 and ORX142. As of mid-to-late April 2026, the transaction progressed through regulatory stages, with preliminary proxy filing completed by April 17, 2026.